FDA Warns Consumers about Counterfeit Alli : RushPRNews - Newswire & Global Press Release Distribution

 
Bookmark and Share

FDA Warns Consumers about Counterfeit Alli

January 19, 2010

Washington, DC (RPRN) 01/19/10 — The counterfeit products contain controlled substance sibutramine

The U.S. Food and Drug Administration is today warning consumers about a counterfeit and potentially harmful version of Alli 60 mg capsules (120 count refill kit).

Preliminary laboratory tests conducted by GlaxoSmithKline (GSK)—the maker of the FDA approved over-the-counter weight-loss product— revealed that the counterfeit version did not contain orlistat, the active ingredient in its product. Instead, the counterfeit product contained the controlled substance sibutramine. Sibutramine is a drug that should not be used in certain patient populations or without physician oversight. Sibutramine can also interact in a harmful way with other medications the consumer may be taking.

Consumers began reporting suspected counterfeit Alli to GSK in early December 2009. GSK has determined that the counterfeit product has been sold over the internet. However, there is no evidence at this time that the counterfeit Alli product has been sold through other channels, such as retail stores.

The counterfeit Alli product looks similar to the authentic product, with a few notable differences. The counterfeit Alli has:

Outer cardboard packaging missing a “Lot” code;

Expiration date that includes the month, day, and year (e.g., 06162010); authentic Alli expiration date includes only the month and year (e.g.,: 05/12);

Packaging in a plastic bottle that has a slightly taller and wider cap with coarser ribbing than the genuine product;

Plain foil inner safety seal under the plastic cap without any printed words; the authentic product seal is printed with “SEALED for YOUR PROTECTION”;

Contains larger capsules with a white powder, instead of small white pellets.

Consumers who believe they have received counterfeit Alli are asked to contact the FDA's Office of Criminal Investigations (OCI) by calling 800-551-3989 or by visiting the OCI Web site (http://www.fda.gov/OCI).

Health care professionals and consumers are encouraged to report adverse events that may be related to the use of these counterfeit products to the FDA's MedWatch Program by phone at 1-800-FDA-1088, by fax at 1-800-FDA-0178, or by mail at: MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787.

 

Media Web Address: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm197857.htm
About the author:

FDA is an agency within the Department of Health and Human Services and consists of seven centers and offices

Click here to see all news from this author/company

Filed Under: FDA- Pharmaceutical news, Health and Fitness, Lifestyle, PRESS RELEASE

RUSH PR NEWS newswire and press release services at rushprnews.com / Anne Howard annehowardpublicist.com

Content- Legal Responsibility - All material is copyrighted - You may repost but you MUST link back to the original post on your page and acknowledge Rush PR News as the news source. Rush PR News is not legally and/or morally responsible for content of press releases, opinions expressed or fact-checking.

Rush PR News cannot be held legally responsible for material published and distributed through its newswire service or published in its press-room and therefore cannot be sued for published material. Third-party must be contacted directly to dispute content.

Rush PR News is not the contact for material published.

RSSFeed PRESS & SOCIAL MEDIA RELEASES

Ultraseal International expands thanks to export success

Ann Arbor, MI 04/23/14 · Ultraseal International, the global leader in solutions to...

Kaigai Lifestyle Properties Announces Addition of a Brazilian Development to its Portfolio

Oakville, ON 04/22/14 · – International real estate advisors, Kaigai Lifestyle Properties,...

The Environmental Impact of Creek Excavation: Where Science and Nature Meet

London, United Kingdom 04/21/14 · Excavation is one of the most important and...

DEA HOLDS ITS EIGHTH PRESCRIPTION DRUG TAKE BACK DAY ON SATURDAY APRIL 26

Washington, D.C. 04/21/14 · -- After collecting more than 1,700 tons of expired,...

3 M's - Making Manners Matter

Windsor, Ontario 04/19/14 · 3 M's Making Manners Matter Getting people to improve...

VHL Developments to Start Phase 2 of 2150Condos Project

Toronto, ON 04/19/14 · VHL Developments is pleased to announce they will...

Zatun Game Studio Releases a List of Tools That Aid in iPhone Development

Ahmedabad, Gujarat, India 04/18/14 · Zatun Game Studio, a leading cross-platform video game...

Miami Boom Signals First Rating Increase Since 2004: Muni Credit

Miami, Florida 04/18/14 · Record demand from international investors is boosting prices...

Canadian actor/producer Corey Large presents the drug drama ‘Kid Cannabis’ out April 18

Los Angeles/Vancouver 04/14/14 ·  For Canadian actor/producer Corey Large, the drug drama...

Newborn Foundation Presents at 13th Design of Medical Devices Conference on Innovation for Developing Nations

MINNEAPOLIS, MN 04/10/14 · - Newborn Foundation co-founder and chairman Annamarie Saarinen...

Uk firms can succeed at exporting, says Ultraseal International

Ann Arbor, MI 04/09/14 · Understanding markets overseas is the key to exporting...

First App Created for General Public by Academy's Sci-Tech Council

Beverly Hills, Calif. 04/07/14 · ACADEMY COLOR PREDICTOR LAUNCHES ON iTUNES –The Academy Color...

Grand Estates Auctions sells highest priced home in five years in Pasco County, Florida.

Charlotte, North Carolina 04/04/14 · Sale achieved at auction sets a new benchmark...